Get started
BEXIMCO PHARM PLC SPON GDR REP ONE ORD SH OF TAKA 10 REG SBEXIMCO PHARM PLC SPON GDR REP ONE ORD SH OF TAKA 10 REG SBEXIMCO PHARM PLC SPON GDR REP ONE ORD SH OF TAKA 10 REG S

BEXIMCO PHARM PLC SPON GDR REP ONE ORD SH OF TAKA 10 REG S

No trades
See on Supercharts
OverviewFinancialsNewsMindsForecastsSeasonals

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪400.54 M‬ USD
Dividend yield (indicated)
4.67%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪52.82 M‬ USD
Revenue (FY)
‪402.19 M‬ USD
Shares float
—
Beta (1Y)
−0.30

About Beximco Pharmaceuticals Plc


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Iqbal Ahmed
Website
beximcopharma.com
Headquarters
Dhaka
Founded
1976
ISIN
US0885792061
FIGI
BBG006XPRF65
Beximco Pharmaceuticals PLC engages in the business of manufacturing and marketing generic pharmaceuticals formulation products covering a wide range of therapeutic categories. Its products include solid, liquid, cream, and ointment, suppositories, metered dose inhaler, dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company was founded by Ahmed Sohail Fasihur Rahman and Ahmed Salman Fasiur Rahman in 1976 and is headquartered in Dhaka, Bangladesh.

Check out other big names from the same industry as BXMPY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.